TITLE

Fatigue assessment of Parkinson's disease patient in clinic: specific versus holistic

AUTHOR(S)
Falup-Pecurariu, Cristian
PUB. DATE
April 2013
SOURCE
Journal of Neural Transmission;Apr2013, Vol. 120 Issue 4, p577
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Fatigue is a frequently encountered non-motor symptom in Parkinson's disease (PD). Being a subjective definition, with no biological markers, it is difficult to describe. Its definition is influenced by the background and culture of the patient. Subtypes of fatigue are peripheral fatigue and mental fatigue. The co-existence of other non-motor symptoms in PD complicates its assessment. Fatigue could be present before, at the time of diagnosis of PD in untreated patients or during the course of the disease. Scales that can be used for evaluation include generic one for a holistic manner and those specifically designed for PD. A scale designed for fatigue should differentiate between PD patients with fatigue and those without fatigue. The next step is to choose between unidimensional which evaluate one dimension and multidimensional scales. We present the main scales which can be used for fatigue assessment and their properties. The scales are presented with some psychometric properties in non-PD population and those properties through validation in PD population. Scales have some properties which could be recommended for screening and/or rating of severity of fatigue in PD.
ACCESSION #
86418911

 

Related Articles

  • Different diagnostic criteria for Parkinson disease: what are the pitfalls? Bhidayasiri, Roongroj; Reichmann, Heinz // Journal of Neural Transmission;Apr2013, Vol. 120 Issue 4, p619 

    As there are no definite diagnostic tests or reliable biomarkers for Parkinson disease (PD), its diagnosis still relies on the presence of a combination of cardinal motor features, along with the exclusion of other causes of Parkinsonism and the presence of some of supportive features. To date,...

  • A2A Receptor Antagonism and Dyskinesia in Parkinson's Disease. Morelli, Micaela; Blandini, Fabio; Simola, Nicola; Hauser, Robert A. // Parkinson's Disease (20420080);2012, p1 

    Dyskinesia, a major complication of treatment of Parkinson's disease (PD), involves two phases: induction, which is responsible for dyskinesia onset, and expression, which underlies its clinical manifestation. The unique cellular and regional distribution of adenosine A2A receptors in basal...

  • Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera. Min Han; Nagele, Eric; DeMarshall, Cassandra; Acharya, Nimish; Nagele, Robert // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Parkinson's disease (PD), hallmarked by a variety of motor disorders and neurological decline, is the second most common neurodegenerative disease worldwide. Currently, no diagnostic test exists to identify sufferers, and physicians must rely on a combination of subjective physical and...

  • Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera. Min Han; Nagele, Eric; DeMarshall, Cassandra; Acharya, Nimish; Nagele, Robert // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Parkinson's disease (PD), hallmarked by a variety of motor disorders and neurological decline, is the second most common neurodegenerative disease worldwide. Currently, no diagnostic test exists to identify sufferers, and physicians must rely on a combination of subjective physical and...

  • Intensive Rehabilitation Treatment in Parkinsonian Patients with Dyskinesias: A Preliminary Study with 6-Month Followup. Frazzitta, Giuseppe; Morelli, Micaela; Bertotti, Gabriella; Felicetti, Guido; Pezzoli, Gianni; Maestri, Roberto // Parkinson's Disease (20420080);2012, p1 

    A major adverse effect of levodopa therapy is the development of dyskinesia, which affects 30-40% of chronically treated Parkinsonian patients. We hypothesized that our rehabilitation protocol might allow a reduction in levodopa dosage without worsening motor performances, thus reducing...

  • Developing Biomarkers for Parkinson's Disease. Kelly, Janis // Neurology Reviews;May2008, Vol. 16 Issue 5, p1 

    The article focuses on a study led by Mikhail Bogdanov on the possible development of biomarkers for Parkinson's disease. The study found a clearer differentiation between the metabolomic profiles of patients with Parkinson's disease versus those without the disease. The study revealed strong...

  • Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. Fanara, Patrizia; Wong, Po-Yin A.; Husted, Kristofor H.; Shanshan Liu; Liu, Victoria M.; Kohlstaedt, Lori A.; Riiff, Timothy; Protasio, Joan C.; Boban, Drina; Killion, Salena; Killian, Maudi; Epling, Lorrie; Sinclair, Elisabeth; Peterson, Julia; Price, Richard W.; Cabin, Deborah E.; Nussbaum, Robert L.; Brühmann, Jörg; Brandt, Roland; Christine, Chadwick W. // Journal of Clinical Investigation;Sep2012, Vol. 122 Issue 9, p3159 

    Progress in neurodegenerative disease research is hampered by the lack of biomarkers of neuronal dysfunction. We here identified a class of cerebrospinal fluid-based (CSF-based) kinetic biomarkers that reflect altered neuronal transport of protein cargo, a common feature of neurodegeneration....

  • Juvenile Parkinsonism: Epidemiology, Diagnosis and Treatment. Thomsen, Teri R.; Rodnitzky, Robert L. // CNS Drugs;2010, Vol. 24 Issue 6, p467 

    Juvenile parkinsonism, with onset prior to age 21 years, is a relatively rare syndrome. It is caused by a group of heterogeneous entities that can present with a clinical picture similar to idiopathic Parkinson's disease or manifest parkinsonism as part of a spectrum of other signs. Diagnostic...

  • CITATIONS AND CLINICIANS' NOTES: MOVEMENT DISORDERS.  // Current Medical Literature: Neurology;2004, Vol. 20 Issue 1, p16 

    Presents abstracts of articles related to movement disorders. "How Valid is Dopamine Transporter Imaging as a Surrogate Marker in Research Trials in Parkinson's Disease," by P. K. Morrish; "The Effects of Frequency in Pallidal Deep Brain Stimulation for Primary Dystonia," by A. Kupsch, S....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics